Chris Plance is a U.S. healthcare pathway architect, with a focus on how new therapeutics and digital health innovations actually make it into complex care markets. He works at the intersection of payment models, value-based care, delivery systems, and commercial channels, helping organizations understand the incentive and operational realities that determine whether innovation scales safely. His work has contributed to some of the first billing codes available for AI-based healthcare solutions, and he has supported clients in building the clinical, economic, and workflow evidence required for national adoption. He applies the same lens to fast-moving categories like GLP-1s, where decentralized channels and consumer-driven demand are reshaping the pharmaceutical value chain. He holds a BS in Computer Engineering from the University of Pittsburgh and an Executive MBA from Rutgers University.
The same forces now at play in medical aesthetics will soon appear in every therapeutic category where treatment overlaps with identity, from hormones to nootropics to genetic optimization.